Error: Could not add to watchlist. X

Aberdeen Swiss Funds Global Pharma Equity Fund

+ Watchlist
SVBPHNI:SW
1,695.92
USD
6.23
0.37%
As of 00:59:30 ET on 09/02/2015.
Fund Type
Open-End Fund
52Wk Range
1,507.10 - 1,852.75
1 Yr Return
5.28%
YTD Return
5.80%
Previous Close
1,689.69
52Wk Range
1,507.10 - 1,852.75
1 Yr Return
5.28%
YTD Return
5.80%
Fund Type
Open-End Fund
Objective
Foreign Blend
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 09/02/2015)
1,695.92
Total Assets (m USD) (on 09/01/2015)
121.267
Inception Date
09/30/1959
Last Dividend (on 11/18/2014)
5.06
Dividend Indicated Gross Yield
0.30%
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
1.66%
Top Fund Holdings
Name Position Value % of Fund
Novo Nordisk A/S 226.80 k 12.64 m 9.51
Novartis AG 123.30 k 12.61 m 9.49
Roche Holding AG 38.80 k 11.36 m 8.55
CVS Health Corp 107.60 k 11.02 m 8.29
Johnson & Johnson 105.50 k 10.56 m 7.95
Baxter International Inc 141.90 k 9.45 m 7.11
Teva Pharmaceutical Industries 139.90 k 8.41 m 6.33
Astellas Pharma Inc 554.10 k 8.09 m 6.09
L'Oreal SA 42.10 k 7.94 m 5.97
Sysmex Corp 116.30 k 6.76 m 5.08
Profile
Aberdeen Swiss Equity Fund Global Pharma is an open-end fund incorporated in Switzerland. The Fund invests worldwide in companies that are active in the pharmaceuticals, biotechnology and medical technology sectors. The Fund focuses on the United States and offers investors a transparent way to invest in the complex pharmaceuticals and biotechnology sectors.
ADDRESS
Credit Suisse Asset Management Funds
Sihlcity - Kalandergasse 4
CH-8070 Zurich
Switzerland
PHONE
41-44-335-11-11 Tel